Photocure ASA (OSL:PHO)

Norway flag Norway · Delayed Price · Currency is NOK
53.60
+0.90 (1.71%)
Mar 13, 2025, 1:38 PM CET
-1.11%
Market Cap 1.43B
Revenue (ttm) 525.39M
Net Income (ttm) -4.81M
Shares Out 26.81M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE 178.00
Dividend n/a
Ex-Dividend Date n/a
Volume 37,506
Average Volume 117,379
Open 53.20
Previous Close 52.70
Day's Range 52.60 - 53.70
52-Week Range 47.00 - 69.00
Beta 0.88
RSI 51.48
Earnings Date Feb 19, 2025

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical p... [Read more]

Sector Healthcare
Founded 1993
Employees 102
Stock Exchange Oslo Børs
Ticker Symbol PHO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.